Aurinia Pharmaceuticals Inc.
AUPH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $73 | $53 | $66 | $83 |
| Short-Term Investments | $279 | $262 | $246 | $275 |
| Receivables | $31 | $40 | $40 | $37 |
| Inventory | $45 | $47 | $46 | $39 |
| Other Curr. Assets | $11 | $7 | $6 | $12 |
| Total Curr. Assets | $439 | $409 | $406 | $447 |
| Property Plant & Equip (Net) | $85 | $89 | $94 | $99 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $4 | $4 | $4 | $4 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $1 | $1 |
| Total NC Assets | $89 | $94 | $99 | $104 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $528 | $503 | $505 | $551 |
| Liabilities | – | – | – | – |
| Payables | $2 | $3 | $4 | $5 |
| Short-Term Debt | $17 | $17 | $16 | $15 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $5 | $5 | $5 | $11 |
| Other Curr. Liab. | $52 | $52 | $44 | $67 |
| Total Curr. Liab. | $76 | $78 | $68 | $98 |
| LT Debt | $61 | $65 | $62 | $64 |
| Deferred Rev, NC | $12 | $12 | $12 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $12 | $12 | $11 | $11 |
| Total NC Liab. | $86 | $89 | $86 | $75 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $61 | $82 | $78 | $64 |
| Total Liabilities | $162 | $167 | $155 | $173 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1,117 | $1,123 | $1,163 | $1,188 |
| Retained Earnings | -$860 | -$892 | -$913 | -$937 |
| AOCI | -$1 | -$1 | -$1 | -$1 |
| Other Equity | $110 | $105 | $101 | $127 |
| Total Equity | $366 | $335 | $350 | $377 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $528 | $503 | $505 | $551 |
| Net Debt | $5 | $29 | $11 | -$4 |